This study concerns contralateral white noise suppression of transient evoked otoacoustic emissions (TEOAEs) in children with auditory processing disorder (APD). Fifty-one children between 7 and 11 years were assigned to 1 of 3 experimental groups: those without auditory complaints (n = 15), those with APD who scored high on a standardized test (n = 20) and those with APD who scored lower on the same test (n = 16). For all groups TEOAE suppression was determined in both linear and nonlinear acquisition mode. The results provide evidence that abnormal TEOAE suppression was significantly more common in the APD groups than in the control group. Contralateral suppression of TEOAE is an additional tool for assessing the efferent pathway in children with APD.
The effect of contralateral acoustic stimulation on transient evoked otoacoustic emissions (TEOAEs) was used to investigate the activity of the medial olivocochlear bundle in neonates. TEOAEs were bilaterally recorded, with and without contralateral noise, in 120 full-term neonates without risk for hearing loss. Otoacoustic emission recordings were carried out using the Otodynamic ILO88 system quickscreener non-linear mode, and the contralateral stimulation was presented at 60 dB SPL delivered by CD player. The results revealed a significant (p<0.01) contralateral suppression of TEOAE response amplitude: 2.32 dB in females and 3.28 dB in males. This study shows that the suppression effect is present in 88.5% of neonates, with a gender difference (greater suppression in males) and frequency effect, suggesting a functional maturation of the medial olivocochlear bundle in the studied population.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.